SEC Form 4 · accession 0001062993-15-002140
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jyrki Mattila
Director
Period of report
Apr 22, 2015
Accepted (ET)
Apr 23, 2015 · 6:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $37.93 | Apr 22, 2015 | A | 15,000 | A | — | Apr 22, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The options were granted on April 22, 2015 and will vest in four equal annual installments beginning on the first anniversary of the grant date.